Last update 28 May 2025

AP-002

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AP-003, LX-001
Target
Bone resorption factor x RANKL
Action
inhibitors, stimulants
Mechanism
Bone resorption factor inhibitors, RANKL inhibitors(Tumor necrosis factor ligand superfamily member 11 inhibitors), Osteoblasts stimulants
Therapeutic Areas
NeoplasmsRespiratory DiseasesSkin and Musculoskeletal Diseases+ [1]
Active Indication-
Inactive Indication
Advanced breast cancerBreast cancer recurrentNon-Small Cell Lung Cancer+ [3]
Originator Organization
MedMelior, Inc.MedMelior, Inc.
Active Organization-
Inactive Organization
MedMelior, Inc.MedMelior, Inc.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
RegulationFast Track (United States), Orphan Drug (United States)
Login to view timeline

Related

1
Clinical Trials associated with AP-002
NCT04143789
/ Unknown statusPhase 1/2
A Phase 1/2 Dose Escalation Study of AP-002 In Patients With Advanced or Recurrent Solid Tumors
100 Clinical Results associated with AP-002
Login to view more data
100 Translational Medicine associated with AP-002
Login to view more data
100 Patents (Medical) associated with AP-002
Login to view more data
100 Deals associated with AP-002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced breast cancerPhase 2
United States
MedMelior, Inc.MedMelior, Inc.
27 Sep 2019
Breast cancer recurrentPhase 2
United States
MedMelior, Inc.MedMelior, Inc.
27 Sep 2019
Non-Small Cell Lung CancerPhase 2
United States
MedMelior, Inc.MedMelior, Inc.
27 Sep 2019
Prostatic CancerPhase 2
United States
MedMelior, Inc.MedMelior, Inc.
27 Sep 2019
Relapsed Solid NeoplasmPhase 2
United States
MedMelior, Inc.MedMelior, Inc.
27 Sep 2019
Solid tumorPhase 2
United States
MedMelior, Inc.MedMelior, Inc.
27 Sep 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free